Literature DB >> 17278203

Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Jon D Dorfman1, Richard Schulick, Michael A Choti, Jean-Francois H Geschwind, Ihab Kamel, Michael Torbenson, Paul J Thuluvath.   

Abstract

AIM: To examine the clinical characteristics of a subgroup of patients with hepatocellular carcinoma (HCC) and compare them to those with known risk factors.
METHODS: We used the HCC database of 306 patients seen at our institution from January 1, 1995 to December 31, 2001. Of the 306 patients, 63 (20%, group 1) had no known risk factors (hepatitis C virus, hepatitis B virus, alcohol, hemochromatosis or cirrhosis from any cause) and 243 (group 2) had one or more risk factors.
RESULTS: The median age was similar in both groups, but there were disproportionate numbers of younger (< 30 years old), older (> 80 years) patients, women (33% vs 18%), and Caucasians (81% vs 52%) in group 1 as compared to group 2. There were fewer Asians (2% vs 11%) and African Americans (13% vs 27%) in group 1. Abdominal pain (70% vs 37%) was more common while gastrointestinal bleeding (0% vs 11%) and ascites (4% vs 17%) were less common in group 1 compared to group 2. Group 1 had larger tumor burden (median size 9.4 cm vs 5.7 cm) at the time of presentation, but there were no differences in the site (right, left or bilateral lesions), or number of tumors between the two groups.
CONCLUSION: HCC patients without identifiable risk factors have different characteristics and clinical presentation compared to those with known risk factors. Absence of cirrhosis and larger tumor burden may explain the differences in the presenting symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17278203      PMCID: PMC4066013          DOI: 10.3748/wjg.v13.i5.781

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

Review 2.  Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies.

Authors:  Kazuhiko Koike
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

3.  Mortality from hepatocellular and biliary cancers: changing epidemiological trends.

Authors:  Satheesh Nair; K Shiv Kumar; Paul J Thuluvath; K S Shivakumar; K Shiva Kumar
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

Review 4.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 5.  Epidemiology of hepatocellular carcinoma.

Authors:  H B el-Serag
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

Review 6.  Hepatocellular carcinoma.

Authors:  K Okuda
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

7.  NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Authors:  Jorge A Marrero; Robert J Fontana; Grace L Su; Hari S Conjeevaram; Dawn M Emick; Anna S Lok
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

Review 8.  Early molecular and genetic determinants of primary liver malignancy.

Authors:  Mark A Feitelson; Jingbo Pan; Zhaorui Lian
Journal:  Surg Clin North Am       Date:  2004-04       Impact factor: 2.741

Review 9.  Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Authors:  Erzsébet Szabó; Csilla Páska; Pál Kaposi Novák; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 10.  Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.

Authors:  Michael C Kew
Journal:  Liver Int       Date:  2003-12       Impact factor: 5.828

View more
  5 in total

Review 1.  Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  Mirko Tarocchi; Simone Polvani; Giada Marroncini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

2.  Hepatocellular carcinoma in patients with no identifiable risk factors.

Authors:  Caitlin A McIntyre; Joanne F Chou; Mithat Gonen; Jinru Shia; Maya Gambarin-Gelwan; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Jeffrey A Drebin; William R Jarnagin; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2020-06-24       Impact factor: 3.647

3.  Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.

Authors:  Kanokwan Pinyopornpanish; Wael Al-Yaman; Srinivasan Dasarathy; Carlos Romero-Marrero; Arthur McCullough
Journal:  Dig Dis Sci       Date:  2021-05-23       Impact factor: 3.487

Review 4.  Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis.

Authors:  Yezaz Ahmed Ghouri; Idrees Mian; Julie H Rowe
Journal:  J Carcinog       Date:  2017-05-29

5.  Current and future disease progression of the chronic HCV population in the United States.

Authors:  Martin Zalesak; Kevin Francis; Alex Gedeon; John Gillis; Kyle Hvidsten; Phyllis Kidder; Hong Li; Derek Martyn; Leslie Orne; Amanda Smith; Ann Kwong
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.